The application discloses a construction method of a
glycogen storage
disease type 3 (GSD III)
zebrafish F0 generation model and application thereof in
drug screening, mixes sgRNA combinations with Cas9
protein, and jointly injects into single-
cell period embryos of
wild type zebrafish to cultivate and obtain F0 generation
zebrafish models with double allelic mutations. The sgRNA combinations comprise a first targeting sequence and a second targeting sequence for an agla
gene, and a third targeting sequence and a fourth targeting sequence for an aglb
gene. The application breaks through the technical barrier that a traditional GSD III zebrafish double knockout homozygous strain construction cycle lasts for 6-12 months, through screening of high-activity sgRNA combinations and a high-concentration Cas9
protein co-injection strategy in the single-
cell period, the application realizes a very high double allelic
mutation rate in the F0 generation, and effectively overcomes the defects of high chimerism and unstable
phenotype in the traditional F0 generation.